Early stage IT and Healthcare Investing

Coulter Pharmaceutical

portfoliocompanies

company snapshot

Coulter Pharmaceutical

Coulter Pharmaceutical developed monoclonal antibody-based anti-cancer drugs that hone in on tumor cells without devastating surrounding healthy tissues. The company's flagship product was the first anti-B1 antibody-based therapy for the treatment of non-Hodgkin's lymphoma. The company merged with Corixa in December 2000, which was subsequently acquired by GlaxoSmithKline.

website
www.gsk.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share